Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
Catherine M. Bollard(Children's National), Helen E. Heslop(Texas Children's Hospital), Adrian P. Gee(Houston Methodist), Karin Straathof(Institute of Child Health), Laura K. Aguilar(Houston Methodist), Cliona M. Rooney(Texas Children's Hospital), Malcolm K. Brenner(Houston Methodist), Dagmar Dilloo(Düsseldorf University Hospital), Alexandra Rousseau(Houston Methodist), B. Gahn(Houston Methodist), George Carrum(Houston Methodist), Melissa M. Hudson(Cincinnati Children's Hospital Medical Center), John W. Sixbey(St. Jude Children's Research Hospital), M. Victoria Gresik(Houston Methodist), M. Helen Huls(Houston Methodist)
Cited by 390
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
|Blood|2004|1.6k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
|Nature reviews. Cancer|2013|864